MYP_148004
Basic Information
Unnamed
Anticancer
Immunology Immunomodulation Immunogenic
Standard
9 amino acids
C59H80N10O12
Standard
Sequence
FFFFKTTAL
Physicochemical Analysis
1121.33 Da
8.75
0.76
0.55
0.0843
1.28
0.05
0.54
-7.81
54.44
0.4444
0.00
0.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
362.60
0.20
13.0
13.0
33.0
81.0
4.0
8.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0022748 VERIFIED: NO
Provenance & Taxonomy
Homo sapiens [Animal]
Neoantigen
9606
Structure & Mods
linear peptide [Linear]
mixed L/D amino-acid peptide [Mixed]
Bio-Activity Profile
Anticancer
melanoma; HLA-B*08:01
0.0628 μM
Predicted HLA-I binding
RECORD: Rec_0181634 VERIFIED: NO
Provenance & Taxonomy
Homo sapiens [Animal]
Neoantigen
9606
Structure & Mods
linear peptide [Linear]
mixed L/D amino-acid peptide [Mixed]
Bio-Activity Profile
Anticancer
melanoma; HLA-C*01:02
0.9492 μM
Predicted HLA-I binding
RECORD: Rec_0188822 VERIFIED: NO
Provenance & Taxonomy
Homo sapiens [Animal]
Neoantigen
9606
Structure & Mods
linear peptide [Linear]
mixed L/D amino-acid peptide [Mixed]
Bio-Activity Profile
Anticancer
melanoma; HLA-C*12:03
0.0293 μM
Predicted HLA-I binding
RECORD: Rec_0261245 VERIFIED: YES
Provenance & Taxonomy
Homo sapiens [Animal]
Neoantigen
9606
Structure & Mods
linear peptide [Linear]
mixed L/D amino-acid peptide [Mixed]
Bio-Activity Profile
Anticancer Immunogenic
melanoma; HLA-C*12:03
Clinical response
RECORD: Rec_0263280 VERIFIED: YES
Provenance & Taxonomy
Homo sapiens [Animal]
Neoantigen
9606
Structure & Mods
linear peptide [Linear]
mixed L/D amino-acid peptide [Mixed]
Bio-Activity Profile
Anticancer Immunogenic
melanoma; HLA-C*07:02
Clinical response
1 2 NEXT LAST
Showing 5 records on this page · Page 1 of 2